🇺🇸 FDA
Patent

US 8535639

Trifunctional imaging agent for monoclonal antibody tumor-targeted imaging

granted A61KA61K49/0032A61K49/0058

Quick answer

US patent 8535639 (Trifunctional imaging agent for monoclonal antibody tumor-targeted imaging) held by The United States of America as Represented by the Secretary of the Department of Health and Human Services expires Mon Sep 12 2033 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America as Represented by the Secretary of the Department of Health and Human Services
Grant date
Tue Sep 17 2013 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Sep 12 2033 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
22
CPC classes
A61K, A61K49/0032, A61K49/0058, A61K51/00, A61K51/1051